EMPLOYMENT AGREEMENT THIS AGREEMENT (the "Agreement"), made in New York, New York as of the 18th day of April, 2000, between Atlantic Technology Ventures, Inc. a Delaware corporation having its offices and principal place of business at 150 Broadway,...Employment Agreement • August 24th, 2000 • Atlantic Technology Ventures Inc • Pharmaceutical preparations • New York
WARRANT TO PURCHASE SHARES OF COMMON STOCK THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD, OFFERED FOR SALE, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF A...Warrant Agreement • May 15th, 1997 • Atlantic Pharmaceuticals Inc • Pharmaceutical preparations • New York
ATLANTIC PHARMACEUTICALS, INC. STOCK OPTION AGREEMENT RECITALS A. The Board has adopted the Plan for the purpose of retaining the services of selected Employees, non-employee members of the Board or the board of directors of any Parent or Subsidiary...Stock Option Agreement • November 8th, 1996 • Atlantic Pharmaceuticals Inc • Pharmaceutical preparations • California
ARTICLE 1 DEFINITIONSAsset Purchase Agreement • November 19th, 2001 • Atlantic Technology Ventures Inc • Pharmaceutical preparations • New York
ARTICLE 1 CORPORATE GOVERNANCE AND MANAGEMENTStockholders Agreement • August 22nd, 2000 • Atlantic Technology Ventures Inc • Pharmaceutical preparations • New York
RecitalsAsset Purchase Agreement • August 20th, 2001 • Atlantic Technology Ventures Inc • Pharmaceutical preparations • Ohio
UNDERWRITING AGREEMENT between TG THERAPEUTICS, INC.Underwriting Agreement • March 9th, 2017 • Tg Therapeutics, Inc. • Pharmaceutical preparations • New York
The undersigned, TG Therapeutics, Inc., a corporation formed under the laws of the State of Delaware (the “Company”), hereby confirms its agreement (this “Agreement”) with Jefferies LLC (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter”) as follows:
TG THERAPEUTICS, INC. 6,320,000 Shares of Common Stock Underwriting AgreementUnderwriting Agreement • December 16th, 2020 • Tg Therapeutics, Inc. • Pharmaceutical preparations • New York
TG Therapeutics, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 6,320,000 shares of common stock, par value $0.001 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 948,000 shares of common stock, par value $0.001 per share, of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of common stock, par value $0.001 per share, of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.
ADDENDUM TO STOCK OPTION AGREEMENTStock Option Agreement • November 8th, 1996 • Atlantic Pharmaceuticals Inc • Pharmaceutical preparations
EXHIBIT 10.4 EMPLOYMENT AGREEMENT AGREEMENT (the "AGREEMENT"), dated as of January 2, 2003, by and between MANHATTAN PHARMACEUTICALS, INC., a Delaware corporation with principal executive offices at 787 Seventh Avenue, 48th Floor, New York, NY 10019...Employment Agreement • May 15th, 2003 • Manhattan Pharmaceuticals Inc • Pharmaceutical preparations • New York
Exhibit 10.5 EMPLOYMENT AGREEMENT AGREEMENT (the "AGREEMENT"), dated as of February 28, 2003, by and between MANHATTAN PHARMACEUTICALS, INC., a Delaware corporation with principal executive offices at 787 Seventh Avenue, 48th Floor, New York, NY 10019...Employment Agreement • May 15th, 2003 • Manhattan Pharmaceuticals Inc • Pharmaceutical preparations • New York
Exhibit 10.64 ASSET PURCHASE AGREEMENTAsset Purchase Agreement • April 1st, 2002 • Atlantic Technology Ventures Inc • Pharmaceutical preparations • Ohio
Exhibit 10.7 EMPLOYMENT AGREEMENT THIS AGREEMENT (the "Agreement"), made in New York, New York as of the 10th day of April, 2000, between Atlantic Technology Ventures, Inc. a Delaware corporation having its executive offices and principal place of...Employment Agreement • August 24th, 2000 • Atlantic Technology Ventures Inc • Pharmaceutical preparations • New York
RECITALS:Securities Purchase Agreement • December 6th, 2001 • Atlantic Technology Ventures Inc • Pharmaceutical preparations • New York
Exhibit 10.4 REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENT (this "Agreement"), dated as of September 28, 2000, by and among Atlantic Technology Ventures, Inc., a Delaware corporation, with headquarters located at 150 Broadway, Suite...Registration Rights Agreement • November 20th, 2000 • Atlantic Technology Ventures Inc • Pharmaceutical preparations • Delaware
Exhibit 10.6 LICENSE AGREEMENT This License Agreement (hereinafter referred to as this "Agreement"), effective as of February 15, 2002 (the "Effective Date"), is entered into by and between Oleoyl-Estrone Developments SL (the "Licensor") and Manhattan...License Agreement • March 12th, 2004 • Manhattan Pharmaceuticals Inc • Pharmaceutical preparations • New York
Exhibit 10.51 AMENDMENT NO. 1 to REGISTRATION RIGHTS AGREEMENT between Atlantic Technology Ventures, Inc. and the Investors Signatory HeretoRegistration Rights Agreement • April 17th, 2001 • Atlantic Technology Ventures Inc • Pharmaceutical preparations
FIRST AMENDMENT TOEmployment Agreement • April 14th, 2003 • Manhattan Pharmaceuticals Inc • Pharmaceutical preparations
EXHIBIT 10.10 EMPLOYMENT AGREEMENT AGREEMENT (the "AGREEMENT"), dated as of January 2, 2004, by and between MANHATTAN PHARMACEUTICALS, INC., a Delaware corporation with principal executive offices at 787 Seventh Avenue, 48th Floor, New York, NY 10019...Employment Agreement • January 13th, 2004 • Manhattan Pharmaceuticals Inc • Pharmaceutical preparations • New York
WHEREAS:Registration Rights Agreement • March 23rd, 2001 • Atlantic Technology Ventures Inc • Pharmaceutical preparations • Illinois
EXHIBIT 10.65 ------------- CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTIONS OF THIS DOCUMENTS HAVE BEEN REDACTED AND HAVE BEEN FILED SEPARATELY WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION LICENSE AGREEMENT by and between ATLANTIC...License Agreement • August 14th, 2002 • Atlantic Technology Ventures Inc • Pharmaceutical preparations • New York
WITNESSETH:Escrow Agreement • November 20th, 2000 • Atlantic Technology Ventures Inc • Pharmaceutical preparations • North Carolina
ARTICLE 1 AUTHORIZATION AND SALE OF SHARESPreferred Stock Purchase Agreement • August 21st, 2000 • Atlantic Technology Ventures Inc • Pharmaceutical preparations • New York
TG THERAPEUTICS, INC. Common Stock (par value $0.001 per share) At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • March 20th, 2020 • Tg Therapeutics, Inc. • Pharmaceutical preparations • New York
AMENDMENT NO. 1 TO ASSET PURCHASE AGREEMENTAsset Purchase Agreement • November 19th, 2001 • Atlantic Technology Ventures Inc • Pharmaceutical preparations • New York
UNDERWRITING AGREEMENTUnderwriting Agreement • July 18th, 2013 • Tg Therapeutics, Inc. • Pharmaceutical preparations • New York
TG Therapeutics, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the underwriters named in Schedule I hereto (the “Underwriters,” or each, an “Underwriter”) for whom Roth Capital Partners, LLC is acting as representative (the “Representative”) an aggregate of 5,700,000 authorized but unissued shares (the “Firm Shares”) of common stock, par value $0.001 per share (the “Common Stock”), of the Company. The Company has granted the Underwriters the option to purchase an aggregate of up to 855,000 shares of Common Stock (the “Option Shares”) as may be necessary to cover over-allotments made in connection with the offering pursuant to Section 4(b) hereof. The Firm Shares and the Option Shares are collectively referred to as the “Shares.”
PLACEMENT AGREEMENT ------------------- This Agreement is made and entered into as of this 6th day of November, 2001 by and between Joseph Stevens & Company, Inc. ("Joseph Stevens") and Atlantic Technology Ventures, Inc. ("the Company"). In...Placement Agreement • December 6th, 2001 • Atlantic Technology Ventures Inc • Pharmaceutical preparations • New York
RECITALSStock Repurchase Agreement • March 14th, 2001 • Atlantic Technology Ventures Inc • Pharmaceutical preparations
WARRANT TO PURCHASE SHARES OF COMMON STOCK THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD, OFFERED FOR SALE, TRANSFERRED, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF A...Warrant Agreement • November 7th, 1996 • Atlantic Pharmaceuticals Inc • Pharmaceutical preparations • California
BY AND AMONGMerger Agreement • May 15th, 1997 • Atlantic Pharmaceuticals Inc • Pharmaceutical preparations • California
THIRD AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • May 15th, 2003 • Manhattan Pharmaceuticals Inc • Pharmaceutical preparations • New York
Warrant No. 2Warrant Agreement • March 31st, 2000 • Atlantic Technology Ventures Inc • Pharmaceutical preparations • Delaware
ATLANTIC PHARMACEUTICALS, INC. AUTOMATIC STOCK OPTION AGREEMENT RECITALS A. The Corporation has implemented an automatic option grant program under the Plan pursuant to which eligible non-employee members of the Board will automatically receive...Automatic Stock Option Agreement • November 8th, 1996 • Atlantic Pharmaceuticals Inc • Pharmaceutical preparations • California
TG THERAPEUTICS, INC. Common Stock (par value $0.001 per share) At-the-Market Issuance Sales AgreementAt-the-Market Issuance Sales Agreement • June 21st, 2013 • Tg Therapeutics, Inc. • Pharmaceutical preparations • New York
ContractWarrant Agreement • May 8th, 2023 • Tg Therapeutics, Inc. • Pharmaceutical preparations • California
THIS WARRANT AND THE SHARES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY STATE SECURITIES LAWS, AND MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR, SUBJECT TO SECTION 11 HEREOF, AN OPINION OF COUNSEL (WHICH MAY BE COMPANY COUNSEL) REASONABLY SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE ACT, OR ANY APPLICABLE STATE SECURITIES LAWS.
